Syringe body
A syringe body for a pharmaceutical syringe is provided. The syringe includes cylindrical cavity, a finger flange, and an anti-slip element. The cylindrical cavity has a first end face with a cone and a second, open end face configured to receive a piston. The finger flange is arranged around a circumference of the second, open end face. The finger flange has a first surface that faces the cone. The anti-slip element is a roughened area on the first surface. The roughened area exhibits an arithmetic mean roughness value between 0.8 μm and 150 μm.
1. A syringe body for a pharmaceutical syringe, comprising:
a cylindrical cavity having a first end face with a cone and a second, open end face configured to receive a piston;
a finger flange arranged around a circumference of the second, open end face, the finger flange having a first surface that faces the cone and a second surface opposite the first surface; and
an anti-slip element defined as a roughened area on the first surface that comprises an irregular random texture having a random distribution of raised and recessed points that is created by a design of a casting mold, the roughened area exhibiting an arithmetic mean roughness value between 10 μm and 50 μm, and wherein the roughened area does not extend to the cylindrical cavity but ends more than 1 mm in front thereof and merges into a smooth surface that then extends to and adjoins the cylindrical cavity,
wherein the cylindrical cavity, finger flange, and anti-slip element are injection molded as one piece with the roughened area avoiding local accumulations of material in the finger flange so that the second surface defines a flat plane together with the second, open end face and so that the syringe body is configured to stably stand on the second surface.
2. The syringe body of claim 1 , wherein the finger flange has a mirror-symmetrical shape with respect to a surface containing an axis of the cylindrical cavity.
3. The syringe body of claim 1 , wherein the second surface faces away from the cone.
4. The syringe body of claim 3 , wherein the second surface is configured to receive a label.
5. The syringe body of claim 4 , wherein at least the finger flange is made of a transparent material such that the roughened area shines through on the second surface to improve readability of the label.
6. The syringe body of claim 1 , wherein the roughened area covers more than 60% of a surface area of the finger flange.
7. The syringe body of claim 1 , wherein the roughened area covers more than 80% of a surface area of the finger flange.
8. The syringe body of claim 1 , wherein the cylindrical cavity, finger flange, and anti-slip element consist of a plastic material.
9. The syringe body of claim 8 , wherein the plastic material comprises cyclic olefin polymer or copolymer.
10. A pharmaceutical or cosmetic syringe, comprising the syringe body of claim 1 and the piston movably disposed in the cylindrical cavity.
11. The syringe of claim 10 , further comprising a fluid in the cylindrical cavity, the fluid being selected from a group consisting of a medical preparation, a cosmetic preparation, a patient-individualized preparation containing a genetically modified substance, a patient-individualized preparation containing a biologically or microbiologically produced or augmented preparation, and a patient-individualized, tumor-specific marker substance.
12. The syringe of claim 10 , further comprising a fluid in the cylindrical cavity, the fluid being selected from a group consisting of an ionizing radiation generating fluid, a radioactive, patient-individualized tumor marker substance, a preparation containing radioactive, patient-individualized gene sequences, and combinations thereof.
13. A syringe body for a pharmaceutical syringe, comprising:
a cylindrical cavity having a first end face with a cone and a second, open end face configured to receive a piston;
a finger flange arranged around a circumference of the second, open end face, the finger flange having a first surface that faces the cone and a second surface opposite the first surface, the second surface is configured to receive a label; and
a roughened area on the first surface that comprises an irregular random texture having a random distribution of raised and recessed points that is created by a design of a casting mold, the roughened area exhibiting an arithmetic mean roughness value between 10 μm and 50 μm, the roughened area does not extend to the cylindrical cavity but ends more than 1 mm in front thereof and merges into a smooth surface that then extends to and adjoins the cylindrical cavity,
wherein the cylindrical cavity, finger flange, and roughened area are injection molded from a transparent material as one piece with the roughened area positioned with respect to a location that receives the label to shine through the transparent material to improve readability of the label when viewed from the second surface when the second surface receives the label.
14. A syringe body for a pharmaceutical syringe, comprising:
a cylindrical cavity having a first end face with a cone and a second, open end face configured to receive a piston;
a finger flange arranged around a circumference of the second, open end face, the finger flange having a first surface that faces the cone and a second surface opposite the first surface, the second surface is configured to receive a label; and
a roughened area on the first surface that comprises an irregular random texture having a random distribution of raised and recessed points that is created by a design of a casting mold, the roughened area exhibiting an arithmetic mean roughness value between 10 μm and 50 μm, the roughened area does not extend to the cylindrical cavity but ends more than 1 mm in front thereof and merges into a smooth surface that then extends to and adjoins the cylindrical cavity,
wherein the cylindrical cavity, finger flange, and roughened area are injection molded from a transparent material as one piece with the roughened area avoiding local accumulations of material in the finger flange such that the second surface defines a flat plane together with the second, open end face so that the syringe body is configured to stably stand on the second surface, and
wherein the roughened area is positioned with respect to a location that receives the label so that the roughened area shines through the transparent material to improve readability of the label when viewed from the second surface when the second surface receives the label.